Covaxin trial starts at Goa’s Redkar Hospital ; Odisha from Wednesday

▴ Covaxin trial starts at Goa’s Redkar Hospital ; Odisha from Wednesday
Goa starts Covaxin trial while AIIMS starts plasma donation centres

Goa Chief Minister Pramod Sawant has said that the human trials of coronavirus vaccine have begun at the state's Redkar Hospital and congratulated the team behind it.

"Human trials of Covaxin, an indigenously developed vaccine for COVID-19, has begun at Redkar Hospital in Goa. This is a testimony of India's immense potential in healthcare innovation. My best wishes to the entire team working on Covaxin," Sawant tweeted on Monday.

The country's top drug regulator had recently given a green signal for human clinical trials for COVID-19 vaccine candidate Covaxin, which has been developed by the Hyderabad-based Bharat Biotech in collaboration with the ICMR and the National Institute of Virology (NIV).

Meanwhile,Dr. Harsh Vardhan, Union Minister of Health and Family Welfare today flagged off a Plasma Donation Campaign at AIIMS Delhi today. The event was co-organized by Delhi Police where 26 police personnel who had recovered from COVID volunteered to donate their blood plasma.

Expressing his gratitude to the Delhi Police for this initiative he said, “It is very sad that a dozen Delhi police personnel died due to Corona. In spite of these casualties, they are doing a great job deploying personnel to contain the spread, while the number of containment zones has jumped from 200 to 600.”

Dr Harsh Vardhan saluted the contribution of these volunteers by conferring certificates to 26 Police constables. Of these, Shri Om Prakash was donating his plasma for the third time today. The Union Minister stated that these donations will have a long-lasting impact on other countrymen who will get inspired to donate their plasma. Every single donor counts in our journey towards victory over COVID-19 and we need more and more of these plasma warriors to help fight the pandemic till a definitive treatment or vaccine is developed, he added.

He acknowledged the huge potential of this strategy and the government’s will to tap into it. He commented, “As of now convalescent plasma therapy has been approved for compassionate use with various plasma banks being set up to ensure round the clock availability. Despite the fact that India has one of the highest cure rates amongst COVID-19 patients, the plasma donations has yet to pick up. I am happy that AIIMS, New Delhi is organising this plasma donation campaign with the support of Delhi Police Corona Warriors.”

Fondly remembering the contribution of Delhi Police as an integral part of the success of Pulse Polio campaign in 1994, Dr Harsh Vardhan stated that tens of thousands of police constables had joined the Abhiyaan and created a huge awareness drive. The 100 phone number was also dedicated for this cause, he reminisced.

Plasma from recovered COVID-19 patients contains protective antibodies to the novel SARS-CoV-2 virus. It can provide immunity to patients of Covid-19 when transfused. Considering its potential benefit, plasma therapy is provided to those patients who are not responding to conventional treatment. Anyone who has recovered from COVID-19, and has completed 28 days after the completion of treatment or home isolation, is between 18 to 60 years of age with a weight of more than 50 kg is eligible to donate their blood plasma. The Blood Bank will assess their eligibility for blood donation and check the level of COVID-19 protective antibody levels in their blood before they can donate. The blood of a survivor usually has a high concentration of such antibodies and when given to a susceptible person, these antibodies circulate in blood, reach tissues and neutralize the virus. The process of donation is completed in one to three hours and plasma can be collected on same day.

Tags : #Goa #Odisha #CovaxinTrial #GoaCM #PramodSawant #AIIMS #DrHarshVardhan #PlasmaDonationCentre #Delhi #LatestCovidNews #IndiaCovidNewsJuly21

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment ResponsesMay 08, 2024
Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect DiscussionsMay 08, 2024
Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across AsiaMay 08, 2024
When Your Body Makes Beer: Exploring the Curious Case of Auto-Brewery SyndromeMay 07, 2024
Hair Today, Gone Tomorrow: Why Guys Go Bald Before Marriage May 07, 2024
Menopausal Transitions and Mental Health: UCL Study Highlights Increased Depression RiskMay 07, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024
Aurobindo Pharma's Bhiwadi Facility Under FDA Scrutiny: Understanding the ObservationsMay 06, 2024
Exploring the Role of Mediator Protein Complex in Cell Division: Implications for Disease ManagementMay 06, 2024
Akshay Tritiya Parna Mahotsav is to be held in the cityMay 04, 2024
Bharti Singh's Battle with Gallstones: Symptoms, Precautions, and Natural RemediesMay 04, 2024
Empowering Women's Health: New Mammogram GuidelinesMay 04, 2024
Rising Temperatures, Rising Risks: Addressing the Challenges of Heat StressMay 04, 2024
Gynoveda, India's First Ayurveda Fertility Company, Expands Reach with New Clinic in Pune, Set to Open 100 Clinics Across India by 2027May 03, 2024
Aptus Value Housing Finance India Limited, a leading Housing Finance Company has declared its financial results for the year ended March 31, 2024. FY 24 ResultsMay 03, 2024
TIPS FOR PREGNANCY CARE DURING SUMMERMay 03, 2024
The deadly intersection: TB and tobacco smoking co-epidemics in Indonesia Dr TARA SINGH BAM – CNSMay 03, 2024
Mintoak Expands Global Footprint with Strategic Leadership AppointmentsMay 03, 2024